Clinical Trials Directory

Trials / Completed

CompletedNCT02481193

Effects of Cisatracurium on Succinylcholine-induced Fasciculations and Myalgia

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
90 (actual)
Sponsor
Yangzhou No.1 People's Hospital · Academic / Other
Sex
All
Age
20 Years – 65 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to investigate the effects of different doses of cisatracurium pretreatment on succinylcholine-induced fasciculations and postoperative myalgia.

Detailed description

Purpose: To investigate the effects of different doses of cisatracurium pretreatment on succinylcholine-induced fasciculations and postoperative myalgia. Methods: Ninety patients scheduled for laparoscopic cholecystectomies were equally randomized into three groups to receive pretreatment of 0.005, 0.01, and 0.02 mg/kg cisatracurium, respectively. General anesthesia was induced 3.5 min later, train of four stimulation was monitored 4.5 min later, succinylcholine 1.5 mg/kg was injected 5 min later, and endotracheal intubation was implemented 6.5 min later. The side effects of cisatracurium, intensity of fasciculations, intubating conditions, time and extent to maximal depression of twitch and time for its recovery to 20% of control value, severity of myalgia at 24 h postoperatively, serum potassium before the induction, at the time of endotracheal intubation, and 5 min after intubation were recorded.

Conditions

Interventions

TypeNameDescription
DRUGCisatracuriumDifferent doses of cisatracurium pretreatment

Timeline

Start date
2013-03-01
Primary completion
2014-01-01
Completion
2014-01-01
First posted
2015-06-25
Last updated
2015-06-25

Source: ClinicalTrials.gov record NCT02481193. Inclusion in this directory is not an endorsement.